Published in Mol Cell Probes on March 03, 2006
Giant magnetoresistive biochip for DNA detection and HPV genotyping. Biosens Bioelectron (2008) 1.84
Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applications. PLoS One (2007) 1.18
PathogenMip assay: a multiplex pathogen detection assay. PLoS One (2007) 1.06
Rapid and highly informative diagnostic assay for H5N1 influenza viruses. PLoS One (2006) 1.00
Peptide nucleic acid-based array for detecting and genotyping human papillomaviruses. J Clin Microbiol (2009) 0.96
Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence? Eur J Cancer (2007) 0.95
p16(INK4A) immunohistochemical staining may be helpful in distinguishing branchial cleft cysts from cystic squamous cell carcinomas originating in the oropharynx. Cancer (2009) 0.86
PathogenMIPer: a tool for the design of molecular inversion probes to detect multiple pathogens. BMC Bioinformatics (2006) 0.81
The Sequencing Bead Array (SBA), a next-generation digital suspension array. PLoS One (2013) 0.78
Evaluation of ProExC as a prognostic marker in oropharyngeal squamous cell carcinomas. Am J Surg Pathol (2012) 0.77
Template tailoring: Accurate determination of heterozygous alleles using peptide nucleic acid and dideoxyNTP. Electrophoresis (2010) 0.75
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
A sequencing method based on real-time pyrophosphate. Science (1998) 21.21
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol (1995) 10.07
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63
Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol (1998) 5.29
Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst (1990) 3.98
Human papillomavirus and cervical cancer. Clin Microbiol Rev (2003) 3.90
Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol (1995) 3.20
Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol (2002) 2.18
Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol (2000) 1.88
Intermethod variation in detection of human papillomavirus DNA in cervical smears. J Clin Microbiol (1995) 1.65
Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol (1992) 1.64
Viruses in the etiology of human genital cancer. Prog Med Virol (1984) 1.54
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol (1997) 1.44
Typing of human papillomavirus by pyrosequencing. Lab Invest (2001) 1.44
Improved performance of pyrosequencing using single-stranded DNA-binding protein. Anal Biochem (2000) 1.37
Molecular detection and genotyping of human papillomavirus. Expert Rev Mol Diagn (2001) 1.29
A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples. J Clin Microbiol (2000) 1.23
Multiple-primer DNA sequencing method. Electrophoresis (2003) 1.21
DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol (2005) 1.21
Type-specific multiple sequencing primers: a novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology. J Mol Diagn (2005) 1.18
Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol (2001) 1.09
Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: candHPV89, candHPV90, and candHPV91. J Infect Dis (2002) 1.08
Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencing. Gynecol Oncol (2005) 1.06
DNA microarray format for detection and subtyping of human papillomavirus. J Clin Microbiol (2004) 1.05
Detection of genital human papillomavirus by single-tube nested PCR and type-specific oligonucleotide hybridization. J Clin Microbiol (1995) 1.02
Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay. J Clin Microbiol (2004) 0.99
Single-tube real-time nested polymerase chain reaction for detecting human papillomavirus DNA. Diagn Mol Pathol (2000) 0.96
Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, São Paulo, Brazil. Int J STD AIDS (1999) 0.92
Escherichia coli single-stranded DNA-binding protein, a molecular tool for improved sequence quality in pyrosequencing. Electrophoresis (2002) 0.90
In situ diagnosis of human papillomaviruses. Clin Lab Med (2000) 0.84
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med (2007) 5.57
Patterns of known and novel small RNAs in human cervical cancer. Cancer Res (2007) 3.46
Multiplex protein assays based on real-time magnetic nanotag sensing. Proc Natl Acad Sci U S A (2008) 3.34
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst (2008) 3.24
Label-Free Impedance Biosensors: Opportunities and Challenges. Electroanalysis (2007) 2.71
Large-scale pyrosequencing of synthetic DNA: a comparison with results from Sanger dideoxy sequencing. Electrophoresis (2006) 2.63
Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms. Hum Mutat (2002) 2.36
2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol (2012) 2.32
Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst (2009) 2.32
The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys (2009) 2.26
Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science (2011) 2.26
Highly-multiplexed barcode sequencing: an efficient method for parallel analysis of pooled samples. Nucleic Acids Res (2010) 2.20
Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. Nano Lett (2005) 2.01
Screening and cervical cancer cure: population based cohort study. BMJ (2012) 1.99
Whole-transcriptome RNAseq analysis from minute amount of total RNA. Nucleic Acids Res (2011) 1.97
Spin valve sensors for ultrasensitive detection of superparamagnetic nanoparticles for biological applications. Sens Actuators A Phys (2006) 1.93
Giant magnetoresistive biochip for DNA detection and HPV genotyping. Biosens Bioelectron (2008) 1.84
Characterization of synthetic DNA bar codes in Saccharomyces cerevisiae gene-deletion strains. Proc Natl Acad Sci U S A (2004) 1.79
Convergent antibody signatures in human dengue. Cell Host Microbe (2013) 1.64
DNA gyrase gene in Neisseria gonorrhoeae as indicator for resistance to ciprofloxacin and species verification. Int J STD AIDS (2005) 1.60
Long-read pyrosequencing using pure 2'-deoxyadenosine-5'-O'-(1-thiotriphosphate) Sp-isomer. Anal Biochem (2002) 1.49
Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer (2002) 1.47
Label-free biosensing with functionalized nanopipette probes. Proc Natl Acad Sci U S A (2009) 1.40
[In Process Citation]. Lakartidningen (2015) 1.38
Single DNA molecule detection using nanopipettes and nanoparticles. Nano Lett (2005) 1.37
Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain. APMIS (2007) 1.33
Sequencing three crocodilian genomes to illuminate the evolution of archosaurs and amniotes. Genome Biol (2012) 1.33
The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J Clin Microbiol (2012) 1.24
Current rectification with poly-l-lysine-coated quartz nanopipettes. Nano Lett (2006) 1.23
Semi-automated library preparation for high-throughput DNA sequencing platforms. J Biomed Biotechnol (2010) 1.22
Multiple-primer DNA sequencing method. Electrophoresis (2003) 1.21
Microfabricated magnetic sifter for high-throughput and high-gradient magnetic separation. J Magn Magn Mater (2009) 1.19
NanoStriDE: normalization and differential expression analysis of NanoString nCounter data. BMC Bioinformatics (2011) 1.19
Use of whole genome sequencing to determine the microevolution of Mycobacterium tuberculosis during an outbreak. PLoS One (2013) 1.19
Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence. Am J Obstet Gynecol (2005) 1.18
Type-specific multiple sequencing primers: a novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology. J Mol Diagn (2005) 1.18
Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applications. PLoS One (2007) 1.18
Methodological improvements of pyrosequencing technology. J Biotechnol (2006) 1.17
Articular cartilage regeneration with autologous marrow aspirate and hyaluronic Acid: an experimental study in a goat model. Arthroscopy (2009) 1.11
DNA-functionalized MFe2O4 (M = Fe, Co, or Mn) nanoparticles and their hybridization to DNA-functionalized surfaces. Langmuir (2005) 1.11
Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing. Int J Antimicrob Agents (2005) 1.10
Giant Magnetoresistive Sensors for DNA Microarray. IEEE Trans Magn (2008) 1.10
Fisher's theorems for multivariable, time- and space-dependent systems, with applications in population genetics and chemical kinetics. Proc Natl Acad Sci U S A (2005) 1.07
PathogenMip assay: a multiplex pathogen detection assay. PLoS One (2007) 1.06
Spaceflight and modeled microgravity effects on microbial growth and virulence. Appl Microbiol Biotechnol (2009) 1.06
Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study. J Clin Microbiol (2013) 1.05
Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int J Cancer (2008) 1.05
Determination of hepatitis C virus genotype by Pyrosequencing. J Virol Methods (2003) 1.05
Progress on plague vaccine development. Appl Microbiol Biotechnol (2011) 1.04
Ultrasensitive mycotoxin detection by STING sensors. Biosens Bioelectron (2010) 1.04
Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer (2013) 1.03
Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. Am J Pathol (2009) 1.02
Functionalized nanopipettes: toward label-free, single cell biosensors. Bioanal Rev (2010) 1.02
Identification of radiation-induced microRNA transcriptome by next-generation massively parallel sequencing. J Radiat Res (2013) 1.02
Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res (2004) 1.02
Frac-seq reveals isoform-specific recruitment to polyribosomes. Genome Res (2013) 1.01
Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas. Genes Chromosomes Cancer (2002) 1.00
Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women. Int J Oncol (2009) 0.99
Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial. Int J Cancer (2013) 0.98
Reversible cation response with a protein-modified nanopipette. Anal Chem (2011) 0.97
Voltage-controlled metal binding on polyelectrolyte-functionalized nanopores. Langmuir (2011) 0.97
Induction of apoptosis in rat lung epithelial cells by multiwalled carbon nanotubes. J Biochem Mol Toxicol (2009) 0.96
Non-enzymatic transfer of sequence information under plausible prebiotic conditions. Biochimie (2010) 0.96
p16INK4A and p14ARF expression pattern by immunohistochemistry in human papillomavirus-related cervical neoplasia. Mod Pathol (2005) 0.96
Voltage controlled nano-injection system for single-cell surgery. Nanoscale (2012) 0.95
Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence? Eur J Cancer (2007) 0.95
Reversible thrombin detection by aptamer functionalized STING sensors. Biosens Bioelectron (2011) 0.94
Analysis of stress responsive genes induced by single-walled carbon nanotubes in BJ Foreskin cells. J Nanosci Nanotechnol (2007) 0.94
Sensitive giant magnetoresistive-based immunoassay for multiplex mycotoxin detection. Biosens Bioelectron (2009) 0.92
Bioluminescence regenerative cycle (BRC) system: theoretical considerations for nucleic acid quantification assays. Biophys Chem (2005) 0.92
Improvements in Pyrosequencing technology by employing Sequenase polymerase. Anal Biochem (2004) 0.91
Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa. Int J Antimicrob Agents (2009) 0.90